The University of Oregon dedicated the first phase of the Phil and Penny Knight Campus for Accelerating Scientific Impact in December of 2020 in Eugene.

Alexandria Real Estate Equities has attained the world's first WELL Health-Safety Rating for laboratory space at Alexandria LaunchLabs in New York City.

Ultragenyx is planning to build a 100,000-sf gene therapy manufacturing facility in Bedford, Mass.

The Centre for Process Innovation (CPI) began construction in October of 2020 on the Medicines Manufacturing Innovation Centre in Inchinnan in the United Kingdom.

Lincoln Property Company is creating a mixed-use campus in Lexington, Mass.

Merck is constructing a $69 million facility for the production of high-potency active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) compounds.

Facility Logix, EwingCole, and Biggins Lacy Shapiro have launched Rapid Reshore & Development (RR&D) to provide turnkey p

Construction began in October of 2020 on the $44.2 million Discovery Square 2 building in Rochester, Minn.

King Street Properties has fully leased a 214,440-sf research facility in Lexington, Mass., to four pharmaceutical companies.

Fujifilm Diosynth Biotechnologies broke ground in August of 2020 on the $55 million Advanced Therapies Innovation Center in College Station, Texas.